(3) Some batches of H3K4me2 antibody are known to cross-react with H3K4me3. Has the H3K4me2 antibody used in CUT&RUN been tested for such cross-reactivity? Heatmaps in the figures indeed show similar ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other ...

Offering a two-in-one approach to delivering targeted therapeutics to patients and providing a versatile solution to the challenges associated with the co-administration of drugs, bispecific ...

1 before BA.2 or omicron before XBB 1.5—had higher peak neutralising antibody titres and more durable immune responses compared with individuals vaccinated for COVID-19 with no previous infection.

Credit: Panchenko Vladimir/Shutterstock. Navigator Medicines has secured $100m in a Series A financing round jointly led by RA Capital Management and Forbion to advance bispecific antibody ...

Deciding on antigen vs. antibody tests when choosing a COVID-19 test is easier when the definitions and their function are clear. These tests represent different ways you can check for SARS-CoV-2, the ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Parenteral immunisation predominantly induces systemic IgG antibody responses and rarely induces strong mucosal IgA and T-cell immunity, resulting in minimal protection against respiratory pathogens.